Clinical trial

High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer

NCT00003032

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date1997-04-25

PhasePHASE3

Study timeline

Study start (actual)1997-04-25Date precision: day

Registry last updated2020-04-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

filgrastimBIOLOGICAL

cisplatinDRUG · verified · RxNorm: cisplatin

cyclophosphamideDRUG · verified · RxNorm: cyclophosphamide

mitoxantrone hydrochlorideDRUG · verified · RxNorm: mitoxantrone hydrochloride

tamoxifen citrateDRUG · verified · RxNorm: tamoxifen citrate

Sponsors & collaborators

NCIC Clinical Trials Grouplead sponsor

Mapped research locations

TorontoOntario, Canada3 MontrealQuebec, Canada3 VancouverBritish Columbia, Canada1 OttawaOntario, Canada1 LondonOntario, Canada1 CalgaryAlberta, Canada1 HamiltonOntario, Canada1 QuébecQuebec, Canada1 WinnipegManitoba, Canada1 HalifaxNova Scotia, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00003032 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.